Hypoglycemia in type 1 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Endocrinology and metabolism clinics of North America (Print)

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ecl.2010.05.003PMID 20723825PMCID PMC2923455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention and Correction of Hypoglycemia

  2011cited by this paper
• Standards of medical care in diabetes--2007.

  2009cited by this paper
• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

  2009cited by this paper
• Comparison of a Multiple Daily Insulin Injection Regime (Basal Once-Daily Glargine plus Mealtime Lispro) and CSII (Lispro) in Type 1 Diabetes: a Randomized Open Parallel Multicenter Study

  2009cited by this paper
• β-Cell–Mediated Signaling Predominates Over Direct α-Cell Signaling in the Regulation of Glucagon Secretion in Humans

  2009cited by this paper
• Standards of Medical Care in Diabetes—2009

  2009cited by this paper
• Antecedent Hypoglycemia Impairs Autonomic Cardiovascular Function

  2009cited by this paper
• The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes

  2009cited by this paper
• Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes

  2009cited by this paper
• Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

  2009cited by this paper
• Beta-Cell-Mediated Signaling Predominates Over Direct Alpha-Cell Signaling in the Regulation of Glucagon Secretion in Humans

  2009cited by this paper
• Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

  2009cited by this paper
• Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.

  2009cited by this paper
• Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes

  2009cited by this paper
• Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition

  2008cited by this paper
• Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes

  2008cited by this paper
• Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes

  2008cited by this paper
• Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes

  2008cited by this paper
• The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis

  2008cited by this paper
• Acute Complications and Drug Misuse Are Important Causes of Death for Children and Young Adults With Type 1 Diabetes

  2008cited by this paper
• The Barrier of Hypoglycemia in Diabetes

  2008cited by this paper
• Preventing hypoglycaemia: what is the appropriate glucose alert value?

  2008cited by this paper
• Sudden death and hypoglycemia

  2008cited by this paper
• Continuous glucose monitoring and intensive treatment of type 1 diabetes.

  2008cited by this paper
• Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited

  2008cited by this paper
• Long-Term Effect of Diabetes and Its Treatment on Cognitive Function

  2008cited by this paper
• Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials.

  2007cited by this paper
• Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus

  2007cited by this paper
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

  2007cited by this paper
• Hypoglycemia, functional brain failure, and brain death.

  2007cited by this paper
• A review of human and analogue insulin trials.

  2007cited by this paper
• Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)

  2007cited by this paper
• Long-term effect of diabetes and its treatment on cognitive function.

  2007cited by this paper
• Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments.

  2006cited by this paper
• Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents

  2006cited by this paper
• Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway

  2006cited by this paper
• Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes.

  2006cited by this paper
• The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes.

  2006cited by this paper
• Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.

  2005cited by this paper
• Insulin analogues.

  2005cited by this paper
• Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus.

  2005cited by this paper
• Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Defining and Reporting Hypoglycemia in Diabetes

  2005cited by this paper
• Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus

  2004cited by this paper
• Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation.

  2004cited by this paper
• Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus

  2004influential reference
• Hypoglycemia as a barrier to glycemic control.

  2004cited by this paper
• Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes.

  2004cited by this paper
• Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia.

  2003cited by this paper
• Hypoglycemia in diabetes.

  2003cited by this paper
• The Endocrine pancreas and regulation of metabolism

  2001cited by this paper
• Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.

  2001cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Decreased epinephrine responses to hypoglycemia during sleep.

  1998cited by this paper
• Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus.

  1998cited by this paper
• Hypoglycemia in the Diabetes Control and Complications Trial

  1997cited by this paper
• Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

  1997cited by this paper
• Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM

  1994cited by this paper
• Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.

  1994cited by this paper
• Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM

  1994cited by this paper
• Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM

  1993cited by this paper
• Alanine and Terbutaline in Treatment of Hypoglycemia in IDDM

  1993cited by this paper
• Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.

  1993cited by this paper
• Mechanism of Awareness of Hypoglycemia: Perception of Neurogenic (Predominantly Cholinergic) Rather Than Neuroglycopenic Symptoms

  1993cited by this paper
• Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

  1991cited by this paper
• Reduced Neuroendocrine and Symptomatic Responses to Subsequent Hypoglycemia After 1 Episode of Hypoglycemia in Nondiabetic Humans

  1991cited by this paper
• Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release

  1988cited by this paper
• Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics.

  1988cited by this paper
• Postexercise Late-Onset Hypoglycemia in Insulin-Dependent Diabetic Patients

  1987cited by this paper
• A Reliable and Reproducible Test for Adequate Glucose Counterregulation in Type I Diabetes Mellitus

  1984cited by this paper
• Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

  1983cited by this paper
• Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect

  1973cited by this paper

• Hospital-Treated Severe Hypoglycemia in Type 1 Diabetes in the US: A Retrospective Claims-Based Study of Diabetes-Related Complications and Direct Medical Costs.

  2026cites this paper
• Antecedent hypoglycaemia impairs glucagon secretion by enhancing somatostatin-mediated negative feedback control

  2026cites this paper
• Addressing Time Delays in Blood Glucose Regulation for T1DM Using a PD Controller and Smith Predictor Method

  2025cites this paper
• Metabolic interventions as adjunctive therapies to insulin in type 1 diabetes: Current clinical landscape and perspectives

  2025cites this paper
• Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes

  2025cites this paper
• Pharmacotherapy of type 1 diabetes - part 1: yesterday

  2025cites this paper
• RAGE gene polymorphism (rs1800625) and type 1 diabetes mellitus: A potential new model for early diagnosis and risk prediction

  2025cites this paper
• The Glycemic Impact of Protein Ingestion in People With Type 1 Diabetes.

  2025cites this paper
• A continuously oxygenated macroencapsulation system enables high-density packing and delivery of insulin-secreting cells

  2025cites this paper
• Patient Experiences and Treatment Satisfaction with Mini-Dose Glucagon as a Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan

  2025cites this paper
• Assessing the Knowledge of Diabetic Patients About Glucagon Use in Hypoglycemia: A Cross-Sectional Study in Riyadh, Saudi Arabia

  2025cites this paper
• Insulin Out‐of‐Pocket Spending Caps and Employer‐Sponsored Insurance: Changes in Out‐of‐Pocket and Total Costs for Insulin and Healthcare

  2025cites this paper
• Diabetic Ketoacidosis and Severe Hypoglycemia Risks with Ipragliflozin/Insulin Versus Insulin in Type 1 Diabetes: A Japanese Real-World Database Study

  2025cites this paper
• Sex-dimorphic beta1-adrenergic receptor regulation of ventromedial hypothalamic nucleus astrocyte glucose sensing and glycogen metabolism

  2025cites this paper
• The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

  2025cites this paper
• Strategies for optimization of hypoglycemia rat models

  2025cites this paper
• Sex-Specific recurrent insulin-induced hypoglycemia (RIIH) effects on ventromedial hypothalamic nucleus astrocyte metabolic sensor expression and glycogen metabolism.

  2025cites this paper
• Targeted proteomics analysis in type 1 diabetes identifies lower agouti-related protein levels in individuals with impaired hypoglycaemia awareness

  2025cites this paper
• Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetes

  2025influential citation
• Ultrastable Insulin-Glucagon Fusion Protein Exploits an Endogenous Hepatic Switch to Mitigate Hypoglycemic Risk.

  2025cites this paper
• Recommendations for recognizing, risk stratifying, treating, and managing children and adolescents with hypoglycemia

  2024cites this paper
• Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial

  2024cites this paper
• Role of the Adrenal Medulla in Hypoglycaemia-Associated Autonomic Failure—A Diabetic Perspective

  2024cites this paper
• A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression

  2024cites this paper
• In Vivo Mouse Abdominal Oxygen Imaging And Assessment of Subcutaneously Implanted Beta Cell Replacement Devices

  2024cites this paper
• Trends in BMI in Latin American Children With New-Onset Type 1 Diabetes Over 3 Years.

  2024cites this paper
• Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial

  2024cites this paper
• Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials

  2024influential citation
• Impaired Awareness of Hypoglycemia and its Risk Factors among Diabetic Patients in Jazan, Saudi Arabia: A Cross-Sectional Study.

  2024cites this paper
• Macromolecules from mushrooms, venoms, microorganisms, and plants for diabetes treatment - Progress or setback?

  2024cites this paper
• Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review

  2024cites this paper
• Factors associated with knowledge and hypoglycemia experience among patients with diabetes mellitus in Ghana: A cross‐sectional study

  2023cites this paper
• Time Spent in Hypoglycemia According to Age and Time of Day: Observations During Closed-Loop Insulin Delivery

  2023cites this paper
• Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis.

  2023cites this paper
• Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

  2023cites this paper
• Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials

  2023cites this paper
• Relationship between depressive and anxiety symptoms and fear of hypoglycemia among adolescents and adults with type 1 diabetes mellitus.

  2023cites this paper
• The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control

  2023cites this paper
• Acute and Chronic Adverse Outcomes of Type 1 Diabetes.

  2023cites this paper
• The efficacy of glucose‐responsive insulin and glucagon delivery on exercise‐induced hypoglycaemia among adults with type 1 diabetes mellitus: A meta‐analysis of randomized controlled trials

  2023cites this paper
• Thermosensitive Microneedles Capable of On Demand Insulin Release for Precise Diabetes Treatment.

  2023cites this paper
• Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study.

  2023cites this paper
• Supporting the Use of a Person's Own Diabetes Technology in the Inpatient Setting.

  2022cites this paper
• Pathophysiology and management of hypoglycemia in diabetes

  2022cites this paper
• Targeted delivery of harmine to xenografted human pancreatic islets promotes robust cell proliferation

  2022cites this paper
• Prevalence of nocturnal hypoglycemia in free-living conditions in adults with type 1 diabetes: What is the impact of daily physical activity?

  2022cites this paper
• Leeno: Type 1 diabetes management training environment using smart algorithms

  2022cites this paper
• Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study

  2022cites this paper
• Reversing Type 1 Diabetes: The Magnifying Potential of Stem Cell Encapsulation

  2022cites this paper
• Safety, efficacy, and cost-effectiveness of insulin degludec U100 versus insulin glargine U300 in adults with type 1 diabetes: a systematic review and indirect treatment comparison

  2022cites this paper
• Medical Devices, Smart Drug Delivery, Wearables and Technology for the treatment of Diabetes Mellitus.

  2022cites this paper
• Suprachiasmatic nucleus-mediated glucose entry into the arcuate nucleus determines the daily rhythm in blood glycemia.

  2022cites this paper
• Prevalence of Vertebral Fractures in Adults with Type 1 Diabetes: DenSiFy Study (Diabetes Spine Fractures).

  2022cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes

  2022cites this paper
• Clinical, hormonal, and biochemical characteristics of 70 chinese children with moderate to severe type 1 diabetic ketoacidosis

  2022cites this paper
• The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2021cites this paper
• SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants with Type 1 Diabetes.

  2021cites this paper
• 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022.

  2021cites this paper
• Bone and fat

  2021cites this paper
• 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2021.

  2021cites this paper
• Norepinephrine Regulation of Ventromedial Hypothalamic Nucleus Astrocyte Glycogen Metabolism

  2021cites this paper
• Sex differences in ventromedial hypothalamic nucleus glucoregulatory transmitter biomarker protein during recurring insulin-induced hypoglycemia

  2021cites this paper
• Hybrid closed‐loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double‐blind, multicentre, multinational, randomized, crossover study

  2021cites this paper
• Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies

  2021cites this paper
• Type 1 diabetes mellitus: much progress, many opportunities.

  2021cites this paper
• Hypoglycemia frequency and treatment satisfaction in patients receiving insulin analogues for treatment of type 1 diabetes mellitus

  2021cites this paper
• Hindbrain catecholamine regulation of ventromedial hypothalamic nucleus glycogen metabolism during acute versus recurring insulin-induced hypoglycemia in male versus female rat

  2021cites this paper
• Technological Ecological Momentary Assessment Tools to Study Type 1 Diabetes in Youth: Viewpoint of Methodologies

  2021cites this paper
• Pancreas transplant in type 1 diabetes mellitus: the emerging role of islet cell transplant

  2021cites this paper
• Safety and Efficacy of Long-Acting Insulins Degludec and Glargine Among Asian Patients With Type 2 Diabetes Mellitus: A Meta-Analysis

  2021cites this paper
• The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program

  2021cites this paper
• Newest Diabetes-Related Technologies for Pediatric Type 1 Diabetes and Its Impact on Routine Care: a Narrative Synthesis of the Literature

  2021cites this paper
• Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus

  2021cites this paper
• Childhood diabetes and sleep

  2021cites this paper
• Prevalence of impaired awareness of hypoglycemia and its risk factors among patients with type 1 diabetes in Saudi Arabia.

  2021cites this paper
• Diretriz BRASPEN de Terapia Nutricional no Diabetes Mellitus

  2020cites this paper
• Characteristics of Hypoglycemic Diabetic Patients Visiting the Emergency Room

  2020cites this paper
• Ultra-High-Performance Liquid Chromatography-Electrospray Ionization-Mass Spectrometry for High-Neuroanatomical Resolution Quantification of Brain Estradiol Concentrations.

  2020cites this paper
• The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD‐5)

  2020cites this paper
• Continuous Glucose and Heart Rate Monitoring in Young People with Type 1 Diabetes: An Exploratory Study about Perspectives in Nocturnal Hypoglycemia Detection

  2020cites this paper
• Hospital care: improving outcomes in type 1 diabetes.

  2020cites this paper
• Role of carnitine in regulation of blood pressure (MAP/SBP) and gene expression of cardiac hypertrophy markers (α/β‐MHC) during insulin‐induced hypoglycaemia: Role of oxidative stress

  2020cites this paper
• Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy

  2020cites this paper
• Hypoglycemic risk exposures in relation to low serum glucose values in ambulatory patients

  2020cites this paper
• Effects of Acute versus Recurrent Insulin-Induced Hypoglycemia on Ventromedial Hypothalamic Nucleus Metabolic-Sensory Neuron AMPK Activity: Impact of Alpha1-Adrenergic Receptor Signaling.

  2020cites this paper
• When Crisis Strikes

  2020cites this paper
• Norepinephrine Regulation of Ventromedial Hypothalamic Nucleus Metabolic-Sensory Neuron 5′-AMP-Activated Protein Kinase Activity: Impact of Estradiol

  2020cites this paper
• Hypoglycemia

  2020cites this paper
• Continuous Glucose Monitoring as a Matter of Justice

  2020influential citation
• Sex-Specific Acclimation of A2 Noradrenergic Neuron Dopamine-β-Hydroxylase and Estrogen Receptor Variant Protein and 5'-AMP-Activated Protein Kinase Reactivity to Recurring Hypoglycemia in Rat.

  2020cites this paper
• Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers

  2019cites this paper
• Has Technology Improved Diabetes Management in Relation to Age, Gender, and Ethnicity?

  2019cites this paper
• Hindbrain lactoprivic regulation of hypothalamic neuron transactivation and gluco-regulatory neurotransmitter expression: Impact of antecedent insulin-induced hypoglycemia.

  2019cites this paper
• 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020

  2019cites this paper
• Impaired awareness of hypoglycemia in children and adolescents with type 1 diabetes mellitus in north of Jordan

  2019cites this paper
• Ipoglicemia: implicazioni cliniche e impatto sulla salute

  2019cites this paper
• Hindbrain estrogen receptor regulation of ventromedial hypothalamic glycogen metabolism and glucoregulatory transmitter expression in the hypoglycemic male rat.

  2019cites this paper
• Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia

  2019cites this paper
• Potential role of hypothalamic microRNAs in regulation of FOS and FTO expression in response to hypoglycemia

  2019cites this paper
• Hindbrain Estrogen Receptor Regulation of Ventromedial Hypothalamic Glycogen Metabolism and Glucoregulatory Transmitter Expression in the Hypoglycemic Female Rat.

  2019cites this paper